Five-year survival following combination radiotherapy and chemotherapy for recurrent mixed mesodermal sarcoma of the ovary.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D010051:Ovarian Neoplasms / Q000401:mortality / Q000628:therapy*; D012509:Sarcoma / Q000401:mortality / Q000628:therapy*; D013997:Time Factors